Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc. specializes in CNS, metabolic critical care, and oncology drugs. FDA‑approved Ryanodex treats malignant hyperthermia; oncology assets Belrapzo, Bendeka. Growing pipeline (EP‑4104, PEMFEXY, EA‑114) supported by collaborations with Combioxin and Tyme.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 134
HQ: Woodcliff Lake

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
EGRX	Eagle Pharmaceuticals Inc. Cap: 0.0B \| P/E: 3.8	EQUITY	NGM	USD	US2697961082	Active	📈